PB Fintech shares hit 52-week high as board approves incorporation of healthcare subsidiary

PB Fintech Ltd

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of PB Fintech rose nearly 5 percent and hit a 52-week high of Rs 2,018.85 on December 4 after the company announced the approval of the incorporation of a wholly owned subsidiary under the proposed names 'PB Healthcare' or 'PB Healthcare Services,' or any other name as approved by the Ministry of Corporate Affairs, Government of India.

At 12.30 PM, PB Fintech shares were trading 4 percent higher at Rs 2,006. Year-to-date, the stock has surged an impressive 147 percent, significantly outperforming the Nifty 50's 13 percent gain during the same period. The stock has also delivered positive monthly returns for three consecutive months now.

Follow our live blog for all the market action

The proposed subsidiary will focus on healthcare services and will be incorporated in India with an authorised share capital of Rs 5 lakh.

The process for incorporating the subsidiary will follow all necessary approvals, including from the relevant authorities such as the Registrar of Companies.

PB Fintech, along with its nominee, will initially subscribe to 50,000 equity shares at a face value of Rs 10 each, aggregating to Rs 5 lakh in cash, thus acquiring 100 percent ownership of the new entity.

Also Read | Policybazaar parent PB Fintech forays into healthcare services

PB Fintech, widely recognised as Policybazaar, is an online platform for insurance and lending products. Through its flagship brands, Policybazaar and Paisabazaar, the company offers easy access to a range of insurance, credit, and other financial products.

PB Fintech reported its Q2 results on November 5, posting a profit of Rs 50.7 crore, a significant turnaround from a loss of Rs 20.2 crore in the same period last year.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.